Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blin ...

On Tuesday, H.C. Wainwright maintained a Buy rating and a stock price target of $18.00 for Tenaya Therapeutics Inc (NASDAQ:TNYA).

Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. The company’s lead product candidate ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...